FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W56463997> ?p ?o ?g. }

• W56463997 endingPage "2190" @default.
• W56463997 startingPage "2183" @default.
• W56463997 abstract "In this dose-finding study, we sought to compare fondaparinux with enoxaparin in patients with acute coronary syndromes (ACS). Fondaparinux is a synthetic pentasaccharide that selectively inhibits activated clotting factor X. It has been demonstrated as effective in preventing thromboembolic complications in orthopedic surgery. Four doses fondaparinux (2.5, 4, 8, or 12 mg once daily) and enoxaparin (1 mg/kg twice daily) were compared, both given for three to seven days, in patients with ACS without persistent ST-segment elevation. The rates of the combined primary end point of death, myocardial infarction, or recurrent ischemia after nine days were 27.9%, 35.9%, 34.7%, 30.3%, and 35.7% in patients allocated to fondaparinux doses of 2.5, 4, 8, and 12 mg and enoxaparin, respectively (p = NS). In the per-protocol analysis (929 patients who received adequate study drug and had adequate ST-segment monitoring), these figures were 30.0%, 43.5%, 41.0%, 34.8%, and 40.2%. Again, no dose response was observed. The lowest event rates were observed in the 2.5-mg fondaparinux group, which had significantly lower rates than the enoxaparin group as well as for 4 and 8 mg fondaparinux in the per-protocol analysis (p < 0.05). Bleeding rates were low and not different among the patient groups. No differences were observed in fondaparinux concentrations in patients with or without death, myocardial infarction, recurrent ischemia, or bleeding events. This dose-finding study revealed no dose response for different fondaparinux doses ranging from 2.5 to 12 mg subcutaneously and suggests that the efficacy and safety of fondaparinux may be similar to that of enoxaparin. Further studies with fondaparinux in ACS might include the lowest dose (2.5 mg) investigated in this study." @default.
• W56463997 created "2016-06-24" @default.
• W56463997 creator A5003979598 @default.
• W56463997 creator A5015610233 @default.
• W56463997 creator A5029278659 @default.
• W56463997 creator A5033136642 @default.
• W56463997 creator A5034786896 @default.
• W56463997 creator A5043759849 @default.
• W56463997 creator A5060267668 @default.
• W56463997 creator A5063041705 @default.
• W56463997 creator A5073006545 @default.
• W56463997 creator A5084922482 @default.
• W56463997 creator A5085798844 @default.
• W56463997 creator A5090147492 @default.
• W56463997 date "2004-06-01" @default.
• W56463997 modified "2023-10-15" @default.
• W56463997 title "A dose-finding study of fondaparinux in patients with non–ST-segment elevation acute coronary syndromes" @default.
• W56463997 cites W1553345686 @default.
• W56463997 cites W1581187193 @default.
• W56463997 cites W1785370385 @default.
• W56463997 cites W2000130043 @default.
• W56463997 cites W2009241504 @default.
• W56463997 cites W2035141322 @default.
• W56463997 cites W2054169479 @default.
• W56463997 cites W2059215195 @default.
• W56463997 cites W2107151252 @default.
• W56463997 cites W2141244349 @default.
• W56463997 cites W2148768541 @default.
• W56463997 cites W2149599987 @default.
• W56463997 cites W2156496314 @default.
• W56463997 cites W2158336299 @default.
• W56463997 cites W2166945512 @default.
• W56463997 cites W2316460201 @default.
• W56463997 cites W2321004276 @default.
• W56463997 cites W2325460018 @default.
• W56463997 cites W259293772 @default.
• W56463997 cites W4212993861 @default.
• W56463997 cites W4235459854 @default.
• W56463997 cites W4237892021 @default.
• W56463997 cites W4253259085 @default.
• W56463997 cites W4256202725 @default.
• W56463997 cites W979638655 @default.
• W56463997 doi "https://doi.org/10.1016/j.jacc.2004.02.051" @default.
• W56463997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15193678" @default.
• W56463997 hasPublicationYear "2004" @default.
• W56463997 type Work @default.
• W56463997 sameAs 56463997 @default.
• W56463997 citedByCount "128" @default.
• W56463997 countsByYear W564639972012 @default.
• W56463997 countsByYear W564639972013 @default.
• W56463997 countsByYear W564639972014 @default.
• W56463997 countsByYear W564639972015 @default.
• W56463997 countsByYear W564639972016 @default.
• W56463997 countsByYear W564639972017 @default.
• W56463997 countsByYear W564639972018 @default.
• W56463997 countsByYear W564639972019 @default.
• W56463997 countsByYear W564639972020 @default.
• W56463997 countsByYear W564639972021 @default.
• W56463997 crossrefType "journal-article" @default.
• W56463997 hasAuthorship W56463997A5003979598 @default.
• W56463997 hasAuthorship W56463997A5015610233 @default.
• W56463997 hasAuthorship W56463997A5029278659 @default.
• W56463997 hasAuthorship W56463997A5033136642 @default.
• W56463997 hasAuthorship W56463997A5034786896 @default.
• W56463997 hasAuthorship W56463997A5043759849 @default.
• W56463997 hasAuthorship W56463997A5060267668 @default.
• W56463997 hasAuthorship W56463997A5063041705 @default.
• W56463997 hasAuthorship W56463997A5073006545 @default.
• W56463997 hasAuthorship W56463997A5084922482 @default.
• W56463997 hasAuthorship W56463997A5085798844 @default.
• W56463997 hasAuthorship W56463997A5090147492 @default.
• W56463997 hasConcept C126322002 @default.
• W56463997 hasConcept C141071460 @default.
• W56463997 hasConcept C164705383 @default.
• W56463997 hasConcept C2771771 @default.
• W56463997 hasConcept C2776877702 @default.
• W56463997 hasConcept C2777557582 @default.
• W56463997 hasConcept C2780868729 @default.
• W56463997 hasConcept C2991741193 @default.
• W56463997 hasConcept C42219234 @default.
• W56463997 hasConcept C500558357 @default.
• W56463997 hasConcept C71924100 @default.
• W56463997 hasConceptScore W56463997C126322002 @default.
• W56463997 hasConceptScore W56463997C141071460 @default.
• W56463997 hasConceptScore W56463997C164705383 @default.
• W56463997 hasConceptScore W56463997C2771771 @default.
• W56463997 hasConceptScore W56463997C2776877702 @default.
• W56463997 hasConceptScore W56463997C2777557582 @default.
• W56463997 hasConceptScore W56463997C2780868729 @default.
• W56463997 hasConceptScore W56463997C2991741193 @default.
• W56463997 hasConceptScore W56463997C42219234 @default.
• W56463997 hasConceptScore W56463997C500558357 @default.
• W56463997 hasConceptScore W56463997C71924100 @default.
• W56463997 hasIssue "12" @default.
• W56463997 hasLocation W564639971 @default.
• W56463997 hasLocation W564639972 @default.
• W56463997 hasOpenAccess W56463997 @default.
• W56463997 hasPrimaryLocation W564639971 @default.

• next